|
| | |
|
Am J Psychiatry 1984; 141:1-9
Copyright © 1984 by American Psychiatric Association
Genesis and evolution of behavioral disorders: from infancy to early adult life
A Thomas and S Chess
The New York Longitudinal Study has followed the behavioral development of
133 subjects from early infancy to early adult life. Special attention has
been given to the systematic clinical evaluation and follow-up of all
subjects presenting any evidence of behavior disorder. The authors present
incidence and outcome data, define the concept of temperament, and briefly
discuss conceptual issues and empirical findings. They found the "goodness
of fit" (consonance between the individual and the environment) concept
useful in tracing developmental sequences. The authors summarize
quantitative analyses identifying significant group correlations between
antecedent variables and early adult outcome and suggest a tentative
classification of the idiosyncratic factors also evident in the clinical
course of individual subjects, with case illustrations.
This article has been cited by other articles:
|
|
|
|
 
S. K. Williams and F. D. Kelly
Relationships Among Involvement, Attachment, and Behavioral Problems in Adolescence: Examining Father's Influence
The Journal of Early Adolescence,
May 1, 2005;
25(2):
168 - 196.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O. Devinsky and E. Gordon
Epileptic seizures progressing into nonepileptic conversion seizures
Neurology,
November 1, 1998;
51(5):
1293 - 1296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Bartolomeo, G. D. Barba, M.-F. Boisse, A.-C. Bachoud-Levi, J.-D. Degos, and F. Boller
Right-side neglect in Alzheimer's disease
Neurology,
October 1, 1998;
51(4):
1207 - 1209.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G. Fillenbaum, B. Peterson, K. A. Welsh-Bohmer, W. A. Kukull, and A. Heyman
Progression of Alzheimer's disease in black and white patients: The CERAD experience, Part XVI
Neurology,
July 1, 1998;
51(1):
154 - 158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Heyman, G. G. Fillenbaum, K. A. Welsh-Bohmer, M. Gearing, S. S. Mirra, R. C. Mohs, B. L. Peterson, and C. F. Pieper
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII
Neurology,
July 1, 1998;
51(1):
159 - 162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Farlow and R. M. Evans
Pharmacologic treatment of cognition in Alzheimer's dementia
Neurology,
July 1, 1998;
51(1_Suppl_1):
S36 - S44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Knopman
Metrifonate for Alzheimer's disease: Is the next cholinesterase inhibitor better?
Neurology,
May 1, 1998;
50(5):
1203 - 1205.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Cummings, P. A. Cyrus, F. Bieber, J. Mas, J. Orazem, B. Gulanski, and The Metrifonate Study Group*
Metrifonate treatment of the cognitive deficits of Alzheimer's disease
Neurology,
May 1, 1998;
50(5):
1214 - 1221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Morris, P. A. Cyrus, J. Orazem, J. Mas, F. Bieber, B. B. Ruzicka, and B. Gulanski
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease
Neurology,
May 1, 1998;
50(5):
1222 - 1230.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Baron, A. J. Escrig, L. Orensanz, and J. M. Gobernado
The Alzheimer's disease assessment scale
Neurology,
May 1, 1998;
50(5):
1516 - 1516.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Freedman, D. Rewilak, T. Xerri, S. Cohen, A. S. Gordon, M. Shandling, and A. G. Logan
L-deprenyl in Alzheimer's disease: Cognitive and behavioral effects
Neurology,
March 1, 1998;
50(3):
660 - 668.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Farlow, D. K. Lahiri, J. Poirier, J. Davignon, L. Schneider, and S. L. Hui
Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease
Neurology,
March 1, 1998;
50(3):
669 - 677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Rogers, M. R. Farlow, R. S. Doody, R. Mohs, L. T. Friedhoff, and Donepezil Study Group*
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Neurology,
January 1, 1998;
50(1):
136 - 145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Welsh-Bohmer and R. C. Mohs
Neuropsychological assessment of Alzheimer's disease
Neurology,
September 1, 1997;
49(3_Suppl_3):
S11 - S13.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Clark, D. Ewbank, A. Lerner, R. Doody, V. W. Henderson, M. Panisset, J. C. Morris, G. G. Fillenbaum, A. Heyman, and the CERAD collaborators
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study
Neurology,
July 1, 1997;
49(1):
70 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Aisen and K. L. Davis
The search for disease-modifying treatment for Alzheimer's disease
Neurology,
May 1, 1997;
48(5_Suppl_6):
35S - 41S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Fisher
Hypomanic symptoms caused by herpes simplex encephalitis
Neurology,
December 1, 1996;
47(6):
1374 - 1378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Thal, G. Schwartz, M. Sano, M. Weiner, D. Knopman, L. Harrell, S. Bodenheimer, M. Rossor, M. Philpot, J. Schor, et al.
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease
Neurology,
December 1, 1996;
47(6):
1389 - 1395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Cummings and D. Kaufer
Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited
Neurology,
October 1, 1996;
47(4):
876 - 883.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Thal, A. Carta, W. R. Clarke, S. H. Ferris, R. P. Friedland, R. C. Petersen, J. W. Pettegrew, E. Pfeiffer, M. A. Raskind, M. Sano, et al.
A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease
Neurology,
September 1, 1996;
47(3):
705 - 711.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Knopman, L. Schneider, K. Davis, S. Talwalker, F. Smith, T. Hoover, and S. Gracon
Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality
Neurology,
July 1, 1996;
47(1):
166 - 177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Schneider, M. R. Farlow, V. W. Henderson, and J. M. Pogoda
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
Neurology,
June 1, 1996;
46(6):
1580 - 1584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Doraiswamy, A. Krishen, F. Stallone, W. L. Martin, N. L.S. Potts, A. Metz, and J. DeVeaugh-Geiss
NSAIDs and cognition in Alzheimer's disease
Neurology,
April 1, 1996;
46(4):
1194 - 1194.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.A. Welsh, G. Fillenbaum, W. Wilkinson, A. Heyman, R.C. Mohs, Y. Stern, L. M. Harrell, S.D. Edland, and D. Beekly
Neuropsychological test performance in African-American* and white patients with Alzheimer's disease
Neurology,
December 1, 1995;
45(12):
2207 - 2211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Losel and T. Bliesener
Some High-risk Adolescents do not Develop Conduct Problems: A Study of Protective Factors
International Journal of Behavioral Development,
December 1, 1994;
17(4):
753 - 777.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. R. Sunde, P. Alex Mabe, and A. Josephson
Difficult Parents: From Adversaries to Partners
Clinical Pediatrics,
April 1, 1993;
32(4):
213 - 219.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. L. Lev, M. J. Dodd, and P. S. Hinds
Patients' Strategies for Adapting to Cancer Treatment
West J Nurs Res,
October 1, 1992;
14(5):
595 - 617.
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1984
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
